Cargando…
Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control
CD4 T cells are central effectors of anti-cancer immunity and immunotherapy, yet the regulation of CD4 tumor-specific T (T(TS)) cells is unclear. We demonstrate that CD4 T(TS) cells are quickly primed and begin to divide following tumor initiation. However, unlike CD8 T(TS) cells or exhaustion progr...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578141/ https://www.ncbi.nlm.nih.gov/pubmed/37651234 http://dx.doi.org/10.1016/j.celrep.2023.113047 |
_version_ | 1785121456031531008 |
---|---|
author | Guo, Mengdi Abd-Rabbo, Diala Bertol, Bruna C. Carew, Madeleine Lukhele, Sabelo Snell, Laura M. Xu, Wenxi Boukhaled, Giselle M. Elsaesser, Heidi Halaby, Marie Jo Hirano, Naoto McGaha, Tracy L. Brooks, David G. |
author_facet | Guo, Mengdi Abd-Rabbo, Diala Bertol, Bruna C. Carew, Madeleine Lukhele, Sabelo Snell, Laura M. Xu, Wenxi Boukhaled, Giselle M. Elsaesser, Heidi Halaby, Marie Jo Hirano, Naoto McGaha, Tracy L. Brooks, David G. |
author_sort | Guo, Mengdi |
collection | PubMed |
description | CD4 T cells are central effectors of anti-cancer immunity and immunotherapy, yet the regulation of CD4 tumor-specific T (T(TS)) cells is unclear. We demonstrate that CD4 T(TS) cells are quickly primed and begin to divide following tumor initiation. However, unlike CD8 T(TS) cells or exhaustion programming, CD4 T(TS) cell proliferation is rapidly frozen in place by a functional interplay of regulatory T cells and CTLA4. Together these mechanisms paralyze CD4 T(TS) cell differentiation, redirecting metabolic circuits, and reducing their accumulation in the tumor. The paralyzed state is actively maintained throughout cancer progression and CD4 T(TS) cells rapidly resume proliferation and functional differentiation when the suppressive constraints are alleviated. Overcoming their paralysis established long-term tumor control, demonstrating the importance of rapidly crippling CD4 T(TS) cells for tumor progression and their potential restoration as therapeutic targets. |
format | Online Article Text |
id | pubmed-10578141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
record_format | MEDLINE/PubMed |
spelling | pubmed-105781412023-10-16 Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control Guo, Mengdi Abd-Rabbo, Diala Bertol, Bruna C. Carew, Madeleine Lukhele, Sabelo Snell, Laura M. Xu, Wenxi Boukhaled, Giselle M. Elsaesser, Heidi Halaby, Marie Jo Hirano, Naoto McGaha, Tracy L. Brooks, David G. Cell Rep Article CD4 T cells are central effectors of anti-cancer immunity and immunotherapy, yet the regulation of CD4 tumor-specific T (T(TS)) cells is unclear. We demonstrate that CD4 T(TS) cells are quickly primed and begin to divide following tumor initiation. However, unlike CD8 T(TS) cells or exhaustion programming, CD4 T(TS) cell proliferation is rapidly frozen in place by a functional interplay of regulatory T cells and CTLA4. Together these mechanisms paralyze CD4 T(TS) cell differentiation, redirecting metabolic circuits, and reducing their accumulation in the tumor. The paralyzed state is actively maintained throughout cancer progression and CD4 T(TS) cells rapidly resume proliferation and functional differentiation when the suppressive constraints are alleviated. Overcoming their paralysis established long-term tumor control, demonstrating the importance of rapidly crippling CD4 T(TS) cells for tumor progression and their potential restoration as therapeutic targets. 2023-09-26 2023-08-30 /pmc/articles/PMC10578141/ /pubmed/37651234 http://dx.doi.org/10.1016/j.celrep.2023.113047 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Article Guo, Mengdi Abd-Rabbo, Diala Bertol, Bruna C. Carew, Madeleine Lukhele, Sabelo Snell, Laura M. Xu, Wenxi Boukhaled, Giselle M. Elsaesser, Heidi Halaby, Marie Jo Hirano, Naoto McGaha, Tracy L. Brooks, David G. Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control |
title | Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control |
title_full | Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control |
title_fullStr | Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control |
title_full_unstemmed | Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control |
title_short | Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control |
title_sort | molecular, metabolic, and functional cd4 t cell paralysis in the lymph node impedes tumor control |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578141/ https://www.ncbi.nlm.nih.gov/pubmed/37651234 http://dx.doi.org/10.1016/j.celrep.2023.113047 |
work_keys_str_mv | AT guomengdi molecularmetabolicandfunctionalcd4tcellparalysisinthelymphnodeimpedestumorcontrol AT abdrabbodiala molecularmetabolicandfunctionalcd4tcellparalysisinthelymphnodeimpedestumorcontrol AT bertolbrunac molecularmetabolicandfunctionalcd4tcellparalysisinthelymphnodeimpedestumorcontrol AT carewmadeleine molecularmetabolicandfunctionalcd4tcellparalysisinthelymphnodeimpedestumorcontrol AT lukhelesabelo molecularmetabolicandfunctionalcd4tcellparalysisinthelymphnodeimpedestumorcontrol AT snelllauram molecularmetabolicandfunctionalcd4tcellparalysisinthelymphnodeimpedestumorcontrol AT xuwenxi molecularmetabolicandfunctionalcd4tcellparalysisinthelymphnodeimpedestumorcontrol AT boukhaledgisellem molecularmetabolicandfunctionalcd4tcellparalysisinthelymphnodeimpedestumorcontrol AT elsaesserheidi molecularmetabolicandfunctionalcd4tcellparalysisinthelymphnodeimpedestumorcontrol AT halabymariejo molecularmetabolicandfunctionalcd4tcellparalysisinthelymphnodeimpedestumorcontrol AT hiranonaoto molecularmetabolicandfunctionalcd4tcellparalysisinthelymphnodeimpedestumorcontrol AT mcgahatracyl molecularmetabolicandfunctionalcd4tcellparalysisinthelymphnodeimpedestumorcontrol AT brooksdavidg molecularmetabolicandfunctionalcd4tcellparalysisinthelymphnodeimpedestumorcontrol |